From owner-cellbiol@net.bio.net Wed Feb 05 22:00:00 1997
Path: biosci!agate!nntpfeed.doc.ic.ac.uk!sunsite.doc.ic.ac.uk!dundee.ac.uk!kbreenmac2
From: (k.c.breen@dundee.ac.uk)
Newsgroups: bionet.cellbiol
Subject: PhD Position
Followup-To: bionet.cellbiol
Date: 29 Jan 1997 19:54:57 GMT
Organization: The University, Dundee, DD1 4HN, Scotland, UK.
Lines: 23
Distribution: world
Message-ID: <5co9uh$qc3@dux.dundee.ac.uk>
NNTP-Posting-Host: kbreenmac2.medschool.dundee.ac.uk

A collaborative studentship between Dr. Kieran Breen and SmithKline Beecham
will be available from 1st October 1997 for the study of presenillin
protein function. Mutations in this protein have been linked to the
familial form of Alzheimer's disease and studies of its function may help
to unravel the early events that occur in the disease process. This project
will provide training in various experimental techniques including
molecular biology and cell culture. Part of the project will be carried out
at the SB Research Centre in Essex.

Further details of the studentship may be obtained from Dr. Kieran Breen,
Neurosciences Institute, Dept. of Pharmacology, University of Dundee,
Ninewells Hospital Medical School, Dundee DD1 9SY, Scotland U.K. 
Applications, in the form of a current CV naming two referees, should also
be sent to Dr. Breen. The closing date for applications is 28th February.To
be eligible for the full award, applicants must comply with U.K. Home
Office residence requirements.

Kieran Breen, Dept. of Pharmacology,                  
University of Dundee,                   
Ninewells Hospital & Medical School,    
Dundee DD1 9SY,Scotland, U.K.                                              
               
k.c.breen@dundee.ac.uk                  

.